Your browser version is outdated. We recommend that you update your browser to the latest version.

News and Events

  • BARDS Team will be  at Micro sphere Summit on 26th September 2017 at The Shilla Hotel, Seoul, South Korea. Please visit our stall
  • BARDS team won best poster ward title  "A Rapid Dual Test for Enteric Coating Integrity and Drug Assay in the Production and Quality Assurance of Controlled Release Microsphere Formulations". at The 8th APS International PharmSci conference held on    5th-7th Sept 2017 at De Havilland Campus, University of Hertfordshire, Hatfield, Herts, UK.
  • A New BARDS industry suite opened in 2017. Book a session to run samples and get to know the technology.
  • Pfizer to early adopt BARDS technology at their R&D facility in Sandwich, England in 2017. 

 

What is BARDS?

Broadband Acoustics Resonance Dissolution Spectroscopy (BARDS) is a patented new platform technology based on an acoustic phenomenon observed when you add a compound to a solvent. A compound generates a unique acoustic profile (see below) at a fixed solvent volume and analyte concentration. The dissolution of an analyte introduces gases trapped between and within particles and also reduces the solubility of gas in solution. This leads to a reproducible change in the compressibility of the solution due to outgassing, which acts to slow down the speed of sound. The sound is induced simply using a magnetic follower to gently tap the inner wall of the vessel. This mechanical energy then dissipates as sound energy resonating through the solution. BARDS applications are universal across food and pharma sectors and include screening of raw materials,  quality control, inter and intra-batch analysis, blend uniformity analysis, detection of counterfeits and  in the pharmaceutical and food industry. A video presentation explaining BARDS by Dara Fitzpatrick, Ph.D. is given below.